centigray.com - April 2005

Case Presentations

Adenocarcinoma of the right lung and the impact of high-dose IGRT

April 2005

PDF

Print

E-mail

Hussain A, Dawson N, Amin P, Engstrom C, Dorsey B, Siegel E, Guo C.
Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer. J Clin Oncol. 2005 Apr 20;23(12):2789-96.

Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT.
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005 Apr 20;23(12):2772-80.

Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE.
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin's Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005 Apr 18;

Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M.
Phase III Study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction Chemotherapy Followed by Either Standard Thoracic Radiotherapy or Hyperfractionated Accelerated Radiotherapy for Patients With Unresectable Stage IIIA and B Non-Small-Cell Lung Cancer. J Clin Oncol. 2005 Apr 18;

Lans TE, Grunhagen DJ, de Wilt JH, van Geel AN, Eggermont AM.
Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs. Ann Surg Oncol. 2005 Mar 31;

Wagner M, Garzotto M, Lemmon D, Eilers KM, Beer TM.
Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer. Urology. 2005 Apr;65(4):799.

Ruffion A, Manel A, Massoud W, Decaussin M, Berger N, Paparel P, Morel-Journel N, Lopez JG, Champetier D, Devonec M, Perrin P.
Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology. 2005 Apr;65(4):703-7.

Hong SK, Kwak C, Jeon HG, Lee E, Lee SE.
Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? Urology. 2005 Apr;65(4):697-702.

Doridot V, Meunier M, El Khoury C, Nos C, Vincent-Salomon A, Sigal-Zafrani B, Clough KB; Institut Curie Breast Cancer Group.
Stereotactic radioguided surgery by siteSelect for subclinical mammographic lesions. Ann Surg Oncol. 2005 Feb;12(2):181-8.

Schmidt CE, Bestmann B, Kuchler T, Longo WE, Kremer B.
Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol. 2005 Feb;12(2):117-23.

Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M.
Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 2005 Feb;12(2):111-6.

Dvorak P, Georg D, Bogner J, Kroupa B, Dieckmann K, Potter R.
Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1572-81.

Takayama K, Nagata Y, Negoro Y, Mizowaki T, Sakamoto T, Sakamoto M, Aoki T, Yano S, Koga S, Hiraoka M.
Treatment planning of stereotactic radiotherapy for solitary lung tumor. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1565-71.

Park HC, Seong J, An JH, Kim J, Kim UJ, Lee BW.
Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1523-34.

Szumacher E, Llewellyn-Thomas H, Franssen E, Chow E, DeBoer G, Danjoux C, Hayter C, Barnes E, Andersson L.
Treatment of bone metastases with palliative radiotherapy: patients' treatment preferences. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1473-81.

Kamath R, Ryken TC, Meeks SL, Pennington EC, Ritchie J, Buatti JM.
Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1467-72.

Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT.
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1460-6.

Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B.
Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1403-7.

Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR.
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1393-402.

Paulino AC, Koshy M, Howell R, Schuster D, Davis LW.
Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1385-92.

Chapet O, Romestaing P, Mornex F, Souquet JC, Favrel V, Ardiet JM, d'Hombres A, Gerard JP.
Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors? Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1371-7.

Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D.
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1355-63.

Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N.
Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1328-36.

Pierce LJ, Griffith KA, Hayman JA, Douglas KR, Lichter AS.
Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1317-27.

Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G.
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16.

Buyyounouski MK, Hanlon AL, Horwitz EM, Uzzo RG, Pollack A.
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1291-8.

Fowler BZ, Crocker IR, Johnstone PA.
Perineural spread of cutaneous malignancy to the brain. Cancer. 2005 Apr 6;103(10):2143-2153

Richards JC, Roden D, Harper CS.
Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin Experiment Ophthalmol. 2005 Apr;33(2):137-41.

Schomas DA, Roeske JC, MacDonald RL, Sweeney PJ, Mehta N, Mundt AJ.
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol. 2005 Apr;28(2):180-7. PMID: 15803014 [PubMed - in process]

Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD.
Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol. 2005 Apr;28(2):173-9.

Hodge CW, Morris CG, Werning JW, Mendenhall WM.
Role of radiotherapy for pleomorphic adenoma. Am J Clin Oncol. 2005 Apr;28(2):148-51.

Lefranc F, Brotchi J, Kiss R.
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 2005 Apr 1;23(10):2411-22. Review.

Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P.
Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol. 2005 Apr 1;23(10):2372-7.

Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen JB.
Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol. 2005 Apr 1;23(10):2325-31.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H.
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005 Apr 1;23(10):2310-7.

Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG.
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005 Apr 1;23(10):2300-9.

Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr.
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005 Apr 1;23(10):2272-9.

Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E.
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol. 2005 Apr 1;23(10):2256-63.

Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R.
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol. 2005 Apr 1;23(10):2145-54.